HALO logo
halo search icon
Ocugen Inc

US$1.36

Price Change Indicator
0.06 (4.62%)
Ocugen Inc
OCGN · NAS

Ocugen Inc

Start Trading OCGN for Free

US$1.36

Price Arrow0.06 (4.62%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusFakey Shakey - Long (Realtime)HALO AllHALO Consensus ValueHALO MomentumNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ocugen Inc Overview

OCGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About OCGN

icon

Website

Ocugen Inc
icon

Telephone

1.484.328.4701

icon

Address

11 Great Valley Parkway, Malvern, PA 19355

Description

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

OCGN Price Chart

Key Stats

Market Cap

US$440.08M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.73 - 2.72

Trade Value (12mth)

US$2,249,953.00

1 week

-6.47%

1 month

-26.55%

YTD

-5.8%

1 year

56.63%

All time high

778.20

Key Fundamentals

EPS 3 yr Growth

-44.10%

EBITDA Margin

NaN%

Operating Cashflow

-$57m

Free Cash Flow Return

-143.90%

ROIC

-171.40%

Interest Coverage

-11.70

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

328m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

OCGN Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
15 May 26
08 May 26

OCGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.26-0.2-0.23locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.26-0.2-0.23locklocklock
Growth
 %locklocklocklock36.222.8-13.4locklocklock
PE
 XlocklocklocklockN/A1.5N/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ocugen Inc (OCGN:NAS)?
Halo FAQ
The current share price of Ocugen Inc (OCGN:NAS) is USD$1.36.
What is the 52-week high share price for Ocugen Inc (OCGN:NAS)?
Halo FAQ
The 52-week high share price for Ocugen Inc (OCGN:NAS) is USD$2.72.
What is the 52-week low share price for Ocugen Inc (OCGN:NAS)?
Halo FAQ
The 52-week low share price for Ocugen Inc (OCGN:NAS) is USD$0.73.
What is the dividend yield for Ocugen Inc (OCGN:NAS)?
Halo FAQ
Ocugen Inc (OCGN:NAS) does not pay a dividend.
What was Ocugen Inc (OCGN:NAS) last dividend payment?
Halo FAQ
Ocugen Inc (OCGN:NAS) does not pay a dividend.
What is the franking level for Ocugen Inc (OCGN:NAS)?
Halo FAQ
Ocugen Inc (OCGN:NAS) has a franking level of 0.00%.
In which sector is Ocugen Inc (OCGN:NAS) classified?
Halo FAQ
Ocugen Inc (OCGN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial